K+ and Ca2+ channel blocking agents increase or decrease stimulus-evoked but not spontaneous quantal transmitter release in sympathetic nerve terminals.
Stjärne
L
L
Department of Physiology, Karolinska Institute, Stockholm, Sweden.
Msghina
M
M
Stjärne
E
E
D015761:4-Aminopyridine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D002104:Cadmium / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004338:Drug Combinations; D004558:Electric Stimulation; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009411:Nerve Endings / Q000378:metabolism*; D009469:Neuromuscular Junction / Q000502:physiology; D009543:Nifedipine / Q000494:pharmacology; D015221:Potassium Channels / Q000187:drug effects*; D013564:Sympathetic Nervous System / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects*; D013757:Tetraethylammonium Compounds / Q000494:pharmacology; D014649:Vas Deferens / Q000294:innervation
D002121:Calcium Channel Blockers; D004338:Drug Combinations; D015221:Potassium Channels; D013757:Tetraethylammonium Compounds; D002104:Cadmium; D000255:Adenosine Triphosphate; D015761:4-Aminopyridine; D009543:Nifedipine